Your browser doesn't support javascript.
loading
Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
Weiss, Pamela F; Xiao, Rui; Brandon, Timothy G; Pagnini, Ilaria; Wright, Tracey B; Beukelman, Timothy; Morgan-DeWitt, Esi; Feudtner, Chris.
Afiliación
  • Weiss PF; From the Department of Pediatric Rheumatology, Department of Pediatrics, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Univer
  • Xiao R; P.F. Weiss, MD, MSCE, Department of Pediatrics, Division of Rheumatology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine; R. Xiao, PhD, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine; T.G. B
  • Brandon TG; From the Department of Pediatric Rheumatology, Department of Pediatrics, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Univer
  • Pagnini I; P.F. Weiss, MD, MSCE, Department of Pediatrics, Division of Rheumatology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine; R. Xiao, PhD, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine; T.G. B
  • Wright TB; From the Department of Pediatric Rheumatology, Department of Pediatrics, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Univer
  • Beukelman T; P.F. Weiss, MD, MSCE, Department of Pediatrics, Division of Rheumatology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine; R. Xiao, PhD, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine; T.G. B
  • Morgan-DeWitt E; From the Department of Pediatric Rheumatology, Department of Pediatrics, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Univer
  • Feudtner C; P.F. Weiss, MD, MSCE, Department of Pediatrics, Division of Rheumatology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine; R. Xiao, PhD, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine; T.G. B
J Rheumatol ; 45(1): 107-114, 2018 01.
Article en En | MEDLINE | ID: mdl-28916542
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Juvenil / Metotrexato / Antirreumáticos / Adalimumab / Infliximab / Etanercept Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Rheumatol Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Juvenil / Metotrexato / Antirreumáticos / Adalimumab / Infliximab / Etanercept Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Rheumatol Año: 2018 Tipo del documento: Article